Giuseppe Lanza

TL;DR: The present review summarizes the current, though admittedly fluid knowledge on the pathophysiology and symptoms of COVID-19 infection and contributes to a more complete understanding of the disease, and may drive the direction of new research.

TL;DR: It is reported that patients with COVID-19 may exhibit a wide range of neurological manifestations, including encephalopathy, encephalitis, seizures, cerebrovascular events, acute polyneuropathy, headache, hypogeusia, and hyposmia, as well as some non-specific symptoms.

TL;DR: The current literature converges on the positive effect of rTMS in the rehabilitation of all clinical manifestations of stroke, except for spasticity and cognitive impairment, where definitive evidence of efficacy cannot be drawn.

TL;DR: Depressed patients exhibit a significant interhemispheric difference in motor cortex excitability, an imbalanced inhibitory or excitatory intracortical neurochemical circuitry, reduced postexercise facilitation, and an impaired long-term potentiation-like response to paired-associative transcranial magnetic stimulation, and these symptoms may indicate disrupted plasticity.